These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9022347)
1. [Study of serum thrombomodulin(TM) levels in patients with hyper- or hypo- thyroidism]. Soma M; Maeda Y; Matsuura R; Sasaki I; Kasakura S; Saeki Y; Ikekubo K; Ishihara T; Kurahachi H; Sasaki S; Tagami T; Nakao K Rinsho Byori; 1997 Jan; 45(1):77-81. PubMed ID: 9022347 [TBL] [Abstract][Full Text] [Related]
2. Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves' disease: TM, a possible new marker of the peripheral activity of thyroid hormones. Morikawa Y; Morikawa A; Makino I J Clin Endocrinol Metab; 1993 Mar; 76(3):609-14. PubMed ID: 7680353 [TBL] [Abstract][Full Text] [Related]
3. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease. Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404 [TBL] [Abstract][Full Text] [Related]
5. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617 [TBL] [Abstract][Full Text] [Related]
6. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study. Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of type IV collagen in patients with various thyroid disease]. Senda Y; Nishibu M; Kawai K; Mizukami Y; Hashimoto T Rinsho Byori; 1993 Dec; 41(12):1338-42. PubMed ID: 8295344 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease. Morishita E; Hashimoto T; Asakura H; Saito M; Yamazaki M; Aoshima K; Yoshida T; Kato H; Matsuda T Thromb Haemost; 1998 May; 79(5):919-23. PubMed ID: 9609221 [TBL] [Abstract][Full Text] [Related]
9. Thyroid function in early and late alcohol withdrawal: relationship with aggression, family history, and onset age of alcoholism. Ozsoy S; Esel E; Izgi HB; Sofuoglu S Alcohol Alcohol; 2006; 41(5):515-21. PubMed ID: 16855000 [TBL] [Abstract][Full Text] [Related]
10. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393 [TBL] [Abstract][Full Text] [Related]
12. [Thyroid function tests]. Uchimura H Rinsho Byori; 2001 Apr; 49(4):319-24. PubMed ID: 11391943 [TBL] [Abstract][Full Text] [Related]
13. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction. Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691 [TBL] [Abstract][Full Text] [Related]
14. The serum osteocalcin levels in patients with thyroid diseases. Simionescu L; Dumitriu L; Dimitriu V; Zamfir-Grigorescu D; Câmpean G; Dumitriu E; Balmeş E; Simescu M; Gudovan E; Ursu H Endocrinologie; 1988; 26(1):27-33. PubMed ID: 3260397 [TBL] [Abstract][Full Text] [Related]
15. The hypothalamic-pituitary-thyroid axis in subjects with subclinical thyroid diseases: the impact of the negative feedback mechanism. Falaschi P; Martocchia A; Proietti A; D'Urso R; Gargano S; Culasso F; Rocco A Neuro Endocrinol Lett; 2004 Aug; 25(4):292-6. PubMed ID: 15361820 [TBL] [Abstract][Full Text] [Related]
16. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
17. Evidence of central hypothyroidism in children on continuous ambulatory peritoneal dialysis. Düsünsel R; Poyrazoglu HM; Gündüz Z; Kurtoglu S; Kiris A; Günes T Adv Perit Dial; 1999; 15():262-8. PubMed ID: 10682115 [TBL] [Abstract][Full Text] [Related]
18. [Serum sex hormone-binding globulin levels in thyroid diseases]. Földes J; Bános C; Lakatos P; Tarján G Orv Hetil; 1990 Jul; 131(29):1579-82. PubMed ID: 2392320 [TBL] [Abstract][Full Text] [Related]
19. [Increased serum PIVKA-II levels in hyperthyroidism]. Morimoto M; Takeda K; Ohara E; Nishimori Y; Hisahara T; Nishida M; Sugiura T Rinsho Byori; 2001 Nov; 49(11):1146-50. PubMed ID: 11769563 [TBL] [Abstract][Full Text] [Related]
20. [An epidemiological study on the relationship between selenium and thyroid function in areas with different iodine intake]. Tong YJ; Teng WP; Jin Y; Li YS; Guan HX; Wang WB; Gao TS; Teng XC; Yang F; Shi XG; Chen W; Man N; Li Z; Guo XJ Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2036-9. PubMed ID: 14703411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]